~~<i id='9671DA997E'><strike id='9671DA997E'><tt id='9671DA997E'><pre id='9671DA997E'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：explore 2025-10-06 14:18:04 Page View：7

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Federal weight loss drug coverage is 30 years out of date
Next article： Anesthesiologist group: stop taking Ozempic before surgery

leisure time

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Wildfire pollution widens asthma inequities on Long Island

Wyandanchisaproud,resilientcommunityonLongIsland.There’sabout13,000peoplewholiveinthispredominantlyB

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Morgan Health, with ambitious aims, wants you to know it’s still here

AdobeSANFRANCISCO—Almostthreeyearsago,thecountry’sbiggestbankunveiledaloftyplantofixthehealthcareind